She draws upon the strength of her network and connections in the community to bring about real action.
Simone is a passionate and determined public health advocate, drawing on both her education and personal experience to campaign for equality of access and greater research into neuroendocrine and other rare cancers, making a difference to the lives of countless families impacted by a cancer diagnosis.
Simone graduated from Loreto Mandeville Hall Toorak in 1994, and has fond memories and lasting friendships from her school days. She completed a Bachelor of Business Management and Marketing degree at Monash University, before commencing her career in the field of advertising, holding senior positions over 12 years at various media corporations including News Corp and Australian Consolidated Press.
In 2011 Simone took on the role of Chief Executive Officer of Neuro Endocrine Cancer Australia, having co-founded the organisation in 2009, after witnessing the huge disparity in treatment and support for less common cancers following the diagnosis of her sister Kate. This experience set up her quest to work for greater access to treatments and diagnostics, to raise funds for the Neuro Endocrine Tumour (NET) Nurse Support Service, clinical trial research, and raise awareness about NET cancers within the medical community and general public.
Simone has authored numerous peer reviewed papers published in a range of journals including the International Journal of Cancer. Simone’s pursuit of equitable access and investment in breakthrough treatments for rare cancers has led to her current role as Director of Global Patient Advocacy and Government Affairs at Telix Pharmaceuticals. She is a determined and persuasive advocate who draws upon the strength of her network and connections in the community to bring about real action that has a direct impact on people's lives.
Simone is a graduate of the Australian Institute of Company Directors, and in 2023 was appointed a Member of the Order of Australia (AM) as part of the Kings Birthday Honours, for significant service to community health, particularly with neuro endocrine cancer organisations.
